Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

The Mike Slive Foundation has named the recipients of six prostate cancer research grants. The grants are aimed at continuing the foundation’s stated mission ...

Living-donor transplantation is an option for some organs. For people over 18 born with two functioning kidneys, they can ...

First patient treated in Phase II portion of clinical trial in metastatic prostate cancer at the West Los Angeles Veterans Administration ...

In a first-of-its-kind unusual case, a doctor ‘transplanted’ cancer accidentally into his own body while performing surgery to remove a tumour from a 32-year-old patient who later died of ...

Tim Campbell has given 78 gallons worth of whole blood, platelets and plasma to the Community Blood Bank over the past 35 years.

Clinical features of the patients with prostate cancer are shown in Table 1. The NK activity of PBMCs (we use cytotoxicity of PBMCs as the synonym of NK activity of PBMCs) was studied by flow ...

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...

Treatment for CLL continues to change. Doctors are using newer targeted cancer drugs. This means a stem cell transplant is now a less common treatment for CLL. You have a transplant using donor cells ...

Around 11,000 tests have now been processed, with 235 people (2.1%) testing positive for a BRCA gene mutation, which increases the risk of breast, ovarian and prostate cancer, enabling them to seek ...

1Masonic Cancer Center, Minneapolis, Minnesota. 6Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. 7Department of ...

According to precedent and due to his status, Yoon will probably be assigned a solitary cell, likely bigger and better appointed than the standard 6.56 square metre (71 square feet) single cells.